0001079973-26-000348
SEC filingLightwave Logic's net loss improved 10% to $20.3M on lower R&D, with minimal licensing revenue; volume production not expected before 2027.
Lightwave Logic's FY2025 MD&A reveals a company still in pre-commercial stage. Total revenue grew 147% to $236,855, reflecting initial licensing and non-recurring engineering (NRE) fees. Cost of sales remained negligible at $6,823, yielding a gross margin of 97.1%. However, operating expenses of $20.99 million overwhelmed revenue, resulting in an operating loss of $20.76 million. The net loss improved 10% to $20.31 million, driven by a 32% reduction in R&D spending ($11.49 million vs $16.81 million) that more than offset a 49% increase in G&A expenses ($9.50 million vs $6.37 million). The R&D decline was attributed to lower prototype development, wafer fabrication, and non-cash stock compensation, while G&A rose due to higher salaries, benefits, and stock awards.
The company operates as a single segment focused on electro-optic polymer materials. No segment-level financials are disclosed. Revenue is derived entirely from licensing and NRE arrangements, with no product sales. The Design Win Cycle framework reports three customer programs in Stage 3 (prototype to final product) and approximately fifteen in earlier stages, but no revenue milestones are tied to these stages.
Management explicitly states that FY2026 revenue, if any, will come from material supply, NRE, or prototype/development activities. Significant commercial production revenue is not expected before FY2027 at the earliest. The company ended FY2025 with $69.0 million in cash, partly from a $32.8 million December 2025 offering, and believes it can fund operations through at least December 2027. Planned cash uses include expanding R&D, adding staff, foundry partnerships, and manufacturing scale-up. The company maintains a fabless materials model and is dependent on customer qualification cycles and foundry capacity.
As of December 31, 2025, Lightwave Logic held $69.0 million in cash and cash equivalents, a significant increase from $27.7 million at year-end 2024. The company has no debt; its only liabilities are operating lease obligations of $2.6 million (current portion $0.2 million, long-term $2.4 million) and trade payables. Total stockholders' equity stands at $74.6 million, up from $33.4 million, primarily due to equity financings. The company states it expects to incur approximately $2.4 million per month in expenditures and that its current cash position can finance operations through at least December 2027.
The Notes disclose operating lease commitments under the amended Colorado lease (128-month term ending in 2033). Undiscounted future minimum lease payments total $3.6 million, with $0.4 million due in 2026 and $1.5 million thereafter. No other purchase commitments, supply agreements, or capital expenditure obligations are disclosed. The company has no debt servicing requirements.
The filings reveal no share buyback programs or dividend payments. Capital allocation is focused on funding operations and R&D. During 2025, the company raised $56.9 million in net cash from financing activities, including $32.8 million from an underwritten offering, $18.8 million from at-the-market sales, and $5.1 million from an institutional investor. Proceeds are intended to support continued commercialization of its electro-optic polymer technology. No debt was issued or repaid.
The company operates as a single reportable segment. For the year ended December 31, 2025, net sales totaled $236,855, all generated outside the United States (as the sole license agreement is with a non-U.S. customer). The operating loss was $20.8 million. Two customers accounted for 55% and 45% of total revenue, respectively. Long-lived assets (property, equipment, intangibles, right-of-use assets) were all located in the U.S. and totaled $9.4 million.
The provided filing excerpt does not contain the actual cash flow statement figures. The document references the Statements of Cash Flows as part of the financial statements but only includes the table of contents and exhibits. No numerical data is available for analysis.